CD4 - CD4 molecule Gene

Species: Canis lupus familiaris (sub-species: familiaris)

Gene Type: protein coding
Gene ID: 403931

CD4 Products (1)

mRNA Protein Name
NM_001003252.1 NP_001003252.1 T-cell surface glycoprotein CD4 precursor
Protein Preferred Names Protein Names

T-cell surface glycoprotein CD4

  • CD4 antigen (p55)

  • T-cell surface antigen T4/Leu-3

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0689A Indinavir sulfate 99.97% Yes
HY-B0426A Olopatadine hydrochloride 99.83% Unkown
HY-15440A Fostemsavir Inhibitor 99.69% Unkown
HY-B0689 Indinavir 99.96% Yes
HY-15440B Fostemsavir Tris Inhibitor 99.78% Unkown
HY-W062109 Olopatadine 98.94% Unkown
HY-135432 Etrasimod arginine Modulator 99.86% Unkown
HY-B0426AR Olopatadine hydrochloride (Standard) / Unkown
HY-B0689B Indinavir sulfate ethanolate / Unkown
Inhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99222 Teplizumab 99.73% Unkown
HY-108831 Natalizumab Inhibitor 99.10% Unkown
HY-P99028 Ibalizumab Inhibitor 99.74% Unkown

Clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-105037 Forigerimod Inhibitor 98.75% Phase 3
HY-148511 Vidutolimod 93.85% Phase 3
HY-13644 Gusperimus / Phase 3
HY-148808 Zelasudil Inhibitor 99.48% Phase 2
HY-14135 BMS 488043 Inhibitor / Phase 2
HY-15440 Temsavir Inhibitor 98.70% Phase 1
HY-P0272 Peptide T Inhibitor 98.68% Phase 1
HY-139780 JNJ-61803534 Inhibitor 99.84% Phase 1
Inhibitory Antibodies (21)
Cat. No. Product Name Effect
Purity Phase
HY-P99266 Zanolimumab 99.33% Phase 3
HY-P9998 Semzuvolimab Inhibitor 97% Phase 3
HY-P991336 Ordastobart Agonist 98% Phase 3
HY-P991214 Tucotuzumab celmoleukin 98.797% Phase 3
HY-P9997 Rosnilimab Agonist 99.19% Phase 2
HY-P99159 Ivuxolimab Activator ≥99.0% Phase 2
HY-P99908 Efineptakin alfa Activator 99.70% Phase 2
HY-P99564 Teropavimab Inhibitor 99.70% Phase 2
HY-P991069 VRC-01 Inhibitor 99.805% Phase 2
HY-P990742 Givastomig Inhibitor 98.556% Phase 2
HY-P990068 Perenostobart Inhibitor 97.00% Phase 2
HY-P991424 GSK2618960 Inhibitor 95.66% Phase 2
HY-P991246 VRC01LS Inhibitor 98.78% Phase 2
HY-P99809 Quavonlimab Inhibitor ≥99.0% Phase 2
HY-P99607 Clenoliximab Inhibitor / Phase 2
HY-P991510 CDX-1140 Agonist / Phase 2
HY-P99911 Efizonerimod alfa Agonist 98.57% Phase 1
HY-P991307 BND-35 / Phase 1
HY-P991436 DF6002 Activator / Phase 1
HY-P991643 MTRX1011A Inhibitor / Phase 1
HY-P991655 AGS-009 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (158)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-150741C ODN 2216 sodium Agonist 98.57% Unkown
HY-P3719 MOG(35-55) amide, mouse, rat 99.88% Unkown
HY-110382 Cyclic-di-GMP disodium Activator 98.78% Unkown
HY-150741 ODN 2216 98.57% Unkown
HY-126675A AS2863619 98.02% Unkown
HY-143712 Allolithocholic acid 99.69% Unkown
HY-P2560 LCMV GP (61-80) 99.80% Unkown
HY-15898 Y-320 99.03% Unkown
HY-120427 Cosalane Antagonist 99.50% Unkown
HY-107780B Cyclic-di-GMP diammonium Activator 99.07% Unkown
HY-134809 Cyclotriazadisulfonamide Inhibitor 98.45% Unkown
HY-P1684 Peptide P60 Inhibitor 98.39% Unkown
HY-P1066 Apelin-17(human, bovine) 98.71% Unkown
HY-Y0788 Indoline 99.89% Unkown
HY-111485 Ertabresib 98.34% Unkown
HY-160267 iPAF1C 99.59% Unkown
HY-164426 HEI3090 Activator 99.00% Unkown
HY-P1064 Apelin-36(human) 98.01% Unkown
HY-W181026 KLF10-IN-1 99.84% Unkown
HY-108136A Bisindolylmaleimide X hydrochloride 98.90% Unkown
HY-124750 NecroX-7 Inhibitor 99.69% Unkown
HY-126675 AS2863619 free base 99.87% Unkown
HY-119347 Cirsilineol Inhibitor 98.0% Unkown
HY-D0976 NF279 98.5% Unkown
HY-P5425A Tetanus Toxin (830–844) TFA 96.13% Unkown
HY-P11303 PADRE peptide Ligand 98.28% Unkown
HY-P1745 InsB (9-23) Ligand 98.98% Unkown
HY-W060417 iST2-1 Inhibitor 99.58% Unkown
HY-P1065 Apelin-36(rat, mouse) 98.59% Unkown
HY-P6312 ESAT6 Epitope Ligand 96.86% Unkown
HY-P5453 CFP10 (71–85) 99.43% Unkown
HY-126037 (±)-ML 209 Antagonist 98.14% Unkown
HY-179089 SBP-1750 Inhibitor 98.05% Unkown
HY-W244412 2,5-Dioxopyrrolidin-1-yl 6-hydrazinylnicotinate hydrochloride 95.0% Unkown
HY-107780 Cyclic-di-GMP Activator 98.18% Unkown
HY-105037A Forigerimod TFA Inhibitor 99.88% Unkown
HY-12465 Z-Ile-Leu-aldehyde 97.0% Unkown
HY-138115 7ß,27-Dihydroxycholesterol Activator 99.58% Unkown
HY-14134 BMS-378806 Inhibitor 98.89% Unkown
HY-157793 SMU-L11 99.64% Unkown
HY-165613 Pam2Cys 99.82% Unkown
HY-76648 NBD-556 Inhibitor 99.75% Unkown
HY-P991754 Anti-Mouse TREM2 Antibody (178) 98.92% Unkown
HY-P992030 FB102 99.17% Unkown
HY-100039 YYA-021 Inhibitor 98.96% Unkown
HY-137640A Sp-8-Br-cAMPS sodium Agonist 99.9% Unkown
HY-162972 PROTAC PD-L1 degrader-2 Degrader 95.23% Unkown
HY-171860 FC-14369 Inhibitor 97.85% Unkown
HY-P1409A ADWX 1 TFA Inhibitor 98.37% Unkown
HY-P5917A Vm24-toxin TFA Inhibitor 97.86% Unkown
HY-Y0781S5 Pyruvic acid-13C,d4 99.80% Unkown
HY-115488A BNM-III-170 Inhibitor 98.48% Unkown
HY-123312 CK-548 Inhibitor 90% Unkown
HY-144002 RIBI-529 / Unkown
HY-146231 SS47 Degrader / Unkown
HY-148432 FGF22-IN-1 Inhibitor 98.07% Unkown
HY-162133 MSA-2-Pt / Unkown
HY-P1064A Apelin-36(human) TFA 99.42% Unkown
HY-16106S Talazoparib-13C,d4 99.31% Unkown
HY-P990304 Anti-Mouse 4-1BBL/CD137L Antibody (TKS-1) Inhibitor ≥95.0% Unkown
HY-187690 HGR4113 / Unkown
HY-106055 Murabutide / Unkown
HY-108136 Bisindolylmaleimide X / Unkown
HY-110382S Cyclic-di-GMP-13C20,15N10 disodium Activator / Unkown
HY-111366 CD12681 Agonist / Unkown
HY-116282W Dextran sulfate sodium salt (MW 6500-10000) Inhibitor / Unkown
HY-117855 NBD-11021 / Unkown
HY-119202 (S)-BMS-378806 / Unkown
HY-121820 DMJ-I-228 Inhibitor / Unkown
HY-123902 Ophiobolin C Inhibitor / Unkown
HY-126675G AS2863619 (GMP) / Unkown
HY-131675 CH-100 / Unkown
HY-134809A Cyclotriazadisulfonamide hydrochloride Inhibitor / Unkown
HY-137618B Rp-dGTPαS / Unkown
HY-143712R Allolithocholic acid (Standard) / Unkown
HY-143712S1 Allolithocholic Acid-d4 / Unkown
HY-144746 PD-1/PD-L1-IN-26 Inhibitor / Unkown
HY-15091 Anisperimus / Unkown
HY-154771S Clopidogrelat-13C,d4 / Unkown
HY-159123 KHK-6 Inhibitor / Unkown
HY-161255 3,4-DAA Inhibitor / Unkown
HY-169335 HIV-1 inhibitor-77 Inhibitor / Unkown
HY-170948 A2AR modulator-1 Modulator / Unkown
HY-171859 FC-14367 Inhibitor / Unkown
HY-171862 Nef ligand-2 / Unkown
HY-171881 BI-5521 Inhibitor / Unkown
HY-173000 STAT3-IN-40 / Unkown
HY-176273 RORγt inverse agonist 35 Agonist / Unkown
HY-176755 CCL-34 Activator / Unkown
HY-177277 HM5023507 Inhibitor / Unkown
HY-179734 PROTAC BRD4 Degrader-41 / Unkown
HY-180563 ADC 38 drug linker / Unkown
HY-181599 XAN-5 / Unkown
HY-181663 PJ27 Inhibitor / Unkown
HY-181673 ICD inducer-2 / Unkown
HY-182674 VGD020 Inhibitor / Unkown
HY-182802 Ferroptosis inducer-15 / Unkown
HY-183784 P2X7R antagonist-1 / Unkown
HY-186205 (Rac)-EGC-M5 / Unkown
HY-B0094S3 Artemisinin-13C,d4 / Unkown
HY-B0426AS2 Olopatadine-d6 hydrochloride / Unkown
HY-B1473S2 Serotonin-13C,D4 / Unkown
HY-D3181 CyGbPF / Unkown
HY-D3334 PE-CF594 / Unkown
HY-N17465 Dendronobiloside D Inhibitor / Unkown
HY-N20707 Castalagin / Unkown
HY-P0272A Peptide T TFA Inhibitor / Unkown
HY-P10308 [(Cys(Bzl)84,Glu(OBzl)85)]CD4 (81-92) / Unkown
HY-P10382 M133 peptide / Unkown
HY-P10593 Influenza A NP (383-391) (HLA-B27) / Unkown
HY-P1065A Apelin-36(rat, mouse) TFA / Unkown
HY-P1066A Apelin-17(human, bovine) TFA / Unkown
HY-P10826 PD-1/PD-L1 inhibitory peptide C8 Inhibitor / Unkown
HY-P11090 TpD / Unkown
HY-P11122 MSP-1 P2 Activator / Unkown
HY-P11490 DPMI-ω Antagonist / Unkown
HY-P11802 CD4 (81-92) (human) Inhibitor / Unkown
HY-P2561 Influenza Matrix Protein (61-72) / Unkown
HY-P3554 Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl Inhibitor / Unkown
HY-P4015 VIP (1-12), human, porcine, rat, ovine Ligand / Unkown
HY-P4902 Retrocyclin-1 Inhibitor / Unkown
HY-P5448 MOG (92–106), mouse, rat / Unkown
HY-P5917 Vm24-toxin Inhibitor / Unkown
HY-P5930 HOXB7 8–25 / Unkown
HY-RS02245 CD4 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W005355S8 Sodium 2-oxobutanoate-13C,d4 98.0% Unkown
HY-W006057AS14 Sodium 3-methyl-2-oxobutanoate-13C,d4 / Unkown
HY-W062109S Olopatadine-d6 / Unkown
HY-W387035 D-α-Methyl DOPA / Unkown
HY-W654058 L-Arginine-13C,d4 dihydrochloride / Unkown
HY-W795993 TJU103 Inhibitor / Unkown
HY-107780A Cyclic-di-GMP sodium Activator / Unkown
HY-111485R Ertabresib (Standard) / Unkown
HY-115488 BNM-III-170 free base Inhibitor / Unkown
HY-117160S2 4-trans-Hydroxy glibenclamide-13C,d4 / Unkown
HY-120630 BMS-663749 Inhibitor / Unkown
HY-123756 NBD-10007 Inhibitor / Unkown
HY-12926 ST7612AA1 / Unkown
HY-15440AS Fostemsavir-d8 Inhibitor / Unkown
HY-173077 PD-L1/LpxC-IN-1 Inhibitor / Unkown
HY-174625 Human IL2 mRNA 92.6% Unkown
HY-174725 Human CXCR4 mRNA / Unkown
HY-174754 Human CCL28 mRNA / Unkown
HY-174765 Human CCL18 mRNA / Unkown
HY-176280 SARS-CoV-2-IN-115 Inhibitor / Unkown
HY-181831 XQ2 Activator / Unkown
HY-181841 TLR8 agonist 10 / Unkown
HY-182376 JRC-I-191 Inhibitor / Unkown
HY-182690 CK147 Inhibitor / Unkown
HY-B0202S4 Irbesartan-13C,d4 / Unkown
HY-B0426AS Olopatadine-d3 hydrochloride / Unkown
HY-B0757 Vitamin E nicotinate Inhibitor / Unkown
HY-N5178 Chloropeptin I Inhibitor / Unkown
HY-RS16540 Cd4 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22972 Cd4 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W013677S1 4-Fluorobenzoic acid-13C,d4 / Unkown
HY-Y0788R Indoline (Standard) / Unkown
HY-110216 5J-4 Inhibitor 95% Unkown
Inhibitory Antibodies (33)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990792 Anti-Mouse CD4 Antibody (GK1.5) Inhibitor 99.16% Unkown
HY-108831A Natalizumab (Anti-CD49d) Inhibitor 99.71% Unkown
HY-P990254 Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) Inhibitor 99% Unkown
HY-P990837 Anti-IL-4 Antibody (MP4-25D2) Inhibitor ≥95.0% Unkown
HY-P99141 Anti-Mouse LAG-3 Antibody (C9B7W) Inhibitor 99% Unkown
HY-P990839 Anti-IFNγ Antibody (B133.5) Inhibitor ≥95.0% Unkown
HY-P990242 Anti-Mouse Galectin-9 Antibody (RG9-1) Inhibitor 95.64% Unkown
HY-P99999 Anti-Mouse CD4 Antibody (YTS 191) Inhibitor / Unkown
HY-P991112 Anti-Mouse CD8α Antibody (YTS169.4) Inhibitor 98.99% Unkown
HY-P990175 Anti-Mouse OX40L/CD134L Antibody (RM134L) Inhibitor 95.00% Unkown
HY-P99680 Keliximab Inhibitor 98.23% Unkown
HY-P990861 Anti-CD4 Antibody (OKT-4) 95.00% Unkown
HY-P991110 Anti-Mouse CD25 Antibody (7D4) Inhibitor ≥99.0% Unkown
HY-P991447 Anti-VSIR/VISTA Antibody (SG7) Inhibitor 98.07% Unkown
HY-P990249 Anti-Mouse DR5/CD262 Antibody (MD5-1) Inhibitor 99.20% Unkown
HY-P990264 Anti-Mouse CD70 Antibody (FR70) Inhibitor 95.00% Unkown
HY-P990796 Anti-Mouse IL-2 Antibody (S4B6-1) Inhibitor 96.97% Unkown
HY-P991479 Amtabafusp alfa 99% Unkown
HY-P991753 Anti-Mouse CCL5 Antibody (R6G9) Inhibitor 97.24% Unkown
HY-P990135 Anti-Rat CD4 Antibody (OX-38) Inhibitor 98.91% Unkown
HY-P992063 Anti-Mouse CD8α Antibody (YTS 105.18) 99.9% Unkown
HY-P990353 Anti-CD4 Antibody (TRX1) Inhibitor 99.28% Unkown
HY-P990857 Anti-CD54/ICAM-1 Antibody (R6-5-D6) Inhibitor / Unkown
HY-P991762 Anti-Rat CD4 Antibody (W3/25) Inhibitor / Unkown
HY-P991824 Anti-Mouse CD4 Antibody (YTS 177) Inhibitor / Unkown
HY-P991892 IT1208 Inhibitor / Unkown
HY-P991892A IT1208 (FUT8-KO) Inhibitor / Unkown
HY-P992056 Anti-Human/Mouse LY6E Antibody (9B12) / Unkown
HY-P992434 OSE-279 / Unkown
HY-P992519 PF-06940434 / Unkown
HY-P99495 Cedelizumab Inhibitor / Unkown
HY-P99790 Priliximab / Unkown
HY-P991318 AR20.5 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CD4 NCBI NCBI:920